This session explores how open access to advanced research facilities and infrastructures can democratize innovation in drug development. The presentations will highlight how shared facilities and associated expertise enable more efficient use of infrastructure and broader participation and collaboration in cutting-edge research. By showcasing successful models and identifying remaining barriers, the session aims to foster dialogue on how to sustain and expand equitable access to high-end technologies, thereby accelerating scientific progress and societal impact.

Chairs: Marlous Kooijman (FAST), Brigitte Drees (PharmaNL)

Speakers: Brigitte Drees (PharmaNL), Robert Sauerwein (InFECT-NL), Marc Bonten (Ecraid)

FIGON Partners: FAST, ZonMw, PharmaNL